Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China

被引:1
|
作者
Liu, Yinfeng [1 ]
Zheng, Jie [1 ]
Xu, Yue [2 ]
Lv, Ji [1 ]
Wu, Zizheng [1 ]
Feng, Kai [1 ]
Liu, Jiani [1 ]
Yan, Weitao [1 ]
Wei, Liguang [1 ]
Zhao, Jiangman [2 ]
Jiang, Lisha [2 ]
Han, Meng [1 ]
机构
[1] First Hosp Qinhuangdao, Breast Dis Diag & Treatment Ctr, Qinhuangdao, Hebei, Peoples R China
[2] Shanghai Biotecan Pharmaceut Co Ltd, Shanghai, Peoples R China
关键词
breast cancer; multi-gene panels; rare genetic variants; in silico protein modeling; pathogenic/likely pathogenic variants; GERMLINE MUTATIONS; ASSOCIATION; BRCA1;
D O I
10.3389/fgene.2023.1271710
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients.Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants' impact on protein structure and function.Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 (15.6%), and BRCA2 (15.0%). ACMG classification identified 7% of patients harboring Pathogenic/Likely Pathogenic (P/LP) variants, with one case displaying a pathogenic BRCA1 mutation linked to triple-negative breast cancer (TNBC). Also identified were two pathogenic MUTYH variants, previously associated with colon cancer but increasingly implicated in breast cancer. Variants of uncertain significance (VUS) were identified in 112 patients, with PTEN c.C804A showing the highest frequency. The role of these variants in sporadic breast cancer oncogenesis was suggested. In-depth exploration of previously unreported variants led to the identification of three potential pathogenic variants: ATM c.C8573T, MSH3 c.A2723T, and CDKN1C c.C221T. Their predicted impact on protein structure and stability suggests a functional role in cancer development.Conclusion: This study reveals a comprehensive overview of the genetic variants landscape in Chinese breast cancer patients, highlighting the prevalence and potential implications of rare variants. We emphasize the value of comprehensive genomic profiling in breast cancer management and the necessity of continuous research into understanding the functional impacts of these variants.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Genetic testing and management of prostate cancer patients with pathogenic germline variants
    Katharina Reiter
    Melanie R. Hassler
    memo - Magazine of European Medical Oncology, 2024, 17 : 51 - 56
  • [42] Genetic testing and management of prostate cancer patients with pathogenic germline variants
    Reiter, Katharina
    Hassler, Melanie R.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (01) : 51 - 56
  • [43] Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients
    Pederson, Holly J.
    Gopalakrishnan, Dharmesh
    Noss, Ryan
    Yanda, Courtney
    Eng, Charis
    Grobmyer, Stephen R.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (04) : 560 - 565
  • [44] A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
    Sun, Li
    Brentnall, Adam
    Patel, Shreeya
    Buist, Diana S. M.
    Bowles, Erin J. A.
    Evans, D. Gareth R.
    Eccles, Diana
    Hopper, John
    Li, Shuai
    Southey, Melissa
    Duffy, Stephen
    Cuzick, Jack
    dos Santos Silva, Isabel
    Miners, Alec
    Sadique, Zia
    Yang, Li
    Legood, Rosa
    Manchanda, Ranjit
    JAMA ONCOLOGY, 2019, 5 (12) : 1718 - 1730
  • [45] Multigene panel testing of triple negative breast cancer patients from Russia
    Abramov, I.
    Ikonnikova, A.
    Korneva, Y.
    Shisterova, O.
    Emelyanova, M.
    Nasedkina, T.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 559 - 559
  • [46] Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer
    Seagle, Hannah M.
    Keller, Samantha R.
    Tavtigian, Sean V.
    Horton, Carolyn
    Holowatyj, Andreana N.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (26) : 4279 - +
  • [47] Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2
    Fabi, Alessandra
    Cortesi, Laura
    Duranti, Simona
    Cordisco, Emanuela Lucci
    Di Leone, Alba
    Terribile, Daniela
    Paris, Ida
    de Belvis, Antonio Giulio
    Orlandi, Armando
    Marazzi, Fabio
    Muratore, Margherita
    Garganese, Giorgia
    Fuso, Paola
    Paoletti, Filippo
    Dell'Aquila, Rossella
    Minucci, Angelo
    Scambia, Giovanni
    Franceschini, Gianluca
    Masetti, Riccardo
    Genuardi, Maurizio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 201
  • [48] Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
    Filorizzo, C.
    Fanale, D.
    Incorvaia, L.
    Barraco, N.
    Bono, M.
    Brando, C.
    Calo, V.
    Cancelliere, D.
    Cucinella, A.
    Dimino, A.
    Fiorino, A.
    Magrin, L.
    Pedone, E.
    Perez, A.
    Pivetti, A.
    Sammataro, S.
    Sciacchitano, R.
    Vaccaro, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S432 - S433
  • [49] Emerging Value of Multigene Panels for Germline Testing in Patients With Neuroendocrine Tumors
    Whitman, Julia
    Shih, Brandon
    Blanco, Amie
    Chan, Salina
    Paciorek, Alan
    Desjardin, Jacqueline
    Dhawan, Mallika Sachdev
    Zhang, Li
    Bergsland, Emily
    PANCREAS, 2019, 48 (03) : 455 - 455
  • [50] Hereditary breast cancer gene variants- multigene panel testing outcome from Sri Lanka
    Padeniya, P. M.
    Abayasekara, M.
    Thanaseelan, C.
    Gnanam, V.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 407 - 408